Pharma and Biotech
Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | n/a | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | n/a | n/a |
Pr/Book | 67.7 |
Latest | F'cast | |
---|---|---|
Revenue | n/a | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | n/a | (0.01) | (2.80)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | n/a | (3.96) | (2.40)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | n/a | (0.96) | (0.30)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | n/a | (1.76) | (0.50)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-24 | n/a | (2.19) | (0.60)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Commercial Progress in USA | 18-Aug-2025 | 07:00 | RNS |
Result of AGM | 30-Jun-2025 | 13:45 | RNS |
Notice of AGM | 06-Jun-2025 | 11:00 | RNS |
No recent information was found.
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 1.40p |
Change Today | 0.100p |
% Change | 7.69 % |
52 Week High | 2.35 |
52 Week Low | 1.30 |
Volume | 1,873,743 |
Shares Issued | 396.39m |
Market Cap | £5.55m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
13:51 | 299,573 @ 1.40p |
12:38 | 240,550 @ 1.46p |
11:18 | 10,000 @ 1.57p |
10:10 | 50,000 @ 1.46p |
09:22 | 173,134 @ 1.58p |
Finance Director | Nigel Ronald Lee |
You are here: research